Two Revised Technical Documents published by WADA

To optimise for archiving, the original image and related documents associated with this article have been removed.

WADA has published two revised Technical Documents. 

WADA’s Technical Documents (TDs) are issued to provide direction to WADA-accredited Laboratories, WADA-approved Laboratories for the Athlete Biological Passport, and other stakeholders, on specific technical or procedural issues.

TDs undergo periodic revisions to reflect scientific and technological advances in the performance of anti-doping analyses and the reporting of analytical results, as part of WADA’s mandate to enhance anti-doping activities under the World Anti-Doping Code. 

The two revised TDs were approved during WADA’s Executive Committee (ExCo) meeting on 17 November 2022 and will come into effect on 1 January 2023. Accordingly, all WADA-approved Athlete Passport Management Units (APMU) and all WADA-accredited Laboratories are required to implement the revised documents by 1 January 2023.

All amendments to the revised documents titled 1) TD2023APMU Athlete Passport Management Unit Requirements and Procedures and 2) TD2023DBS Dried Blood Spots For Doping Control can be seen here

You may also like

View All

Dallas judge prohibits NCAA and SEC from banning 41 athletes from returning to college sport for one more season

A Dallas judge has prohibited the National Collegiate Athletic Association and the Southeastern Conference from banning a number of athletes, 3 of which are part of NFL rosters, from returning to college sport for one more season 

Read More

Abuse victims receive over $3 million from Australian Institute of Sport

The Australian Institute of Sport has collectively paid over $3 million to over 225 athletes who experienced abuse at Australia’s elite sports training centre

Read More

Sport Resolutions’ 2025/26 Annual Report is ready to view

Sport Resolutions’ 2025/26 Annual Report is now live, providing a transparent, comprehensive summary of Sport Resolutions’ activity and profile across the last financial year (1 April 2025 – 31 March 2026), including some of our most notable concluded national and international cases and their outcomes

Read More